Free Trial
NASDAQ:MOR

MorphoSys (MOR) Stock Price, News & Analysis

MorphoSys logo
$18.96 0.00 (0.00%)
As of 07/11/2025

About MorphoSys Stock (NASDAQ:MOR)

Key Stats

Today's Range
$18.96
$18.96
50-Day Range
$18.96
$18.96
52-Week Range
$4.18
$19.50
Volume
N/A
Average Volume
1.02 million shs
Market Capitalization
$2.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.

MOR Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Novartis shutters MorphoSys sites, lays off staff
Novartis raises mid-term sales guidance
See More Headlines

MOR Stock Analysis - Frequently Asked Questions

MorphoSys' stock was trading at $18.96 on January 1st, 2025. Since then, MOR shares have increased by 0.0% and is now trading at $18.96.

MorphoSys (MOR) raised $200 million in an initial public offering (IPO) on Thursday, April 19th 2018. The company issued 8,300,000 shares at $24.12 per share. Goldman Sachs, J.P. Morgan and Leerink Partners served as the underwriters for the IPO and Berenberg Capital Markets and JMP Securities were co-managers.

Shares of MOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MorphoSys investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), e.l.f. Beauty (ELF), EMCOR Group (EME), Disc Medicine (IRON) and Builders FirstSource (BLDR).

Company Calendar

Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MOR
CIK
1340243
Employees
730
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.48)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$205.35 million
Net Margins
-226.79%
Pretax Margin
-225.77%
Return on Equity
-694.31%
Return on Assets
-22.55%

Debt

Debt-to-Equity Ratio
4.98
Current Ratio
1.38
Quick Ratio
1.38

Sales & Book Value

Annual Sales
$238.28 million
Price / Sales
11.99
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.35 per share
Price / Book
54.17

Miscellaneous

Outstanding Shares
150,621,000
Free Float
150,546,000
Market Cap
$2.86 billion
Optionable
Not Optionable
Beta
1.20
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MOR) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners